Navigation Links
New Breed Cats Marketed

A biotechnology firm in San Diego, California, Allerca, Inc., is now taking orders for its Allerca Gene Divergence (GD) kitten, the world’s first hypoallergenic cats //.This is a boon to the several allergy sufferers who are also cat lovers.

Allerca sources claim that they searched for natural variations in the cat gene that induces allergy-inducing properties and then promoted the desired trait through breeding. Hence these animals were not transgenic,in other words their genes remain unaltered.

Leslie Lyons, assistant professor in the school of veterinary medicine at the University of California, specializes in research on domestic cat genetics but is not involved in Allerca's work. She supports the company’s work and suggests that Allerca should concentrate on breeding Siberian cats, known for being hypoallergenic or any other such low-allergen breeds,that can be found through genetic screening. She also opined that hypoallergenic breeds could be developed in as few as "one to two crosses.'

Allerca's CEO, Megan Young, says that the firm has taken selective breeding to the next level. Human-exposure trials conducted by Allerca in collaboration with an independent lab revealed that known cat-allergy sufferers ranging from the mildly to the highly allergic, developed no reaction when they came in contact with the newly bred cats.

Allerca’s scientific data,is closely guarded while independent parties have yet to publicly verify the cats' hypoallergenic status.
,
But Young indicated that that Allerca plans to publish its findings in a peer-reviewed journal by 2007.


'"/>




Page: 1

Related medicine news :

1. A New Breed Of Mice Might Hold The Key For Depression Treatment
2. Breeding Mosquitoes Soon to be a Criminal Offence
3. AIIMS Campus - A Breeding Ground for Mosquitoes
4. Breeding success by delving into the honey bee sex gene
5. Public Urged To Prevent Mosquito Breeding
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Biovac, Hepatitis A Vaccine Marketed By Wockhardt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... ... 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce a ... solid foundation. As experts in dangerous situations the Inflow IQ team can help ... deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... 2017 The global reprocessed ... the top five players accounting for nearly 94% ... are Stryker Sustainability Solutions, Ethicon (Johnson & Johnson), ... VANGUARD AG. Despite the high level of consolidation, ... the prevalence of fierce competition among the key ...
(Date:3/23/2017)... -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) today ... Phase 1 study of MM-310 in solid tumors. MM-310 ... taxane and targets the EphA2 receptor, a protein which ... tumor types, including prostate, ovarian, bladder, gastric, pancreatic and ... is an important step in evaluating MM-310,s safety and ...
Breaking Medicine Technology: